Market cap agnostic product that shortlists stocks that improved their working in latest trailing twelve months (TTM) over previous TTM and compares their Expected Market Price (EMP) with current market prices (CMP) dynamically to pick those with highest scope to grow (Gap between CMP and EMP). Diversification across a minimum of 5 industries is assured. Portfolios are assured to have only performing stocks with further scope to grow from current prices at all times, greatly enhancing the prospect to outperform bench-mark with ease.
Subscribe to Bio Growth
Decide the investment amount
Provide approval upon the recommendations